Phenex Pharmaceuticals Aktiengesellschaft
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Holding
- Established
- 2002-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.phenex-pharma.com
Clinical Trials
4
Active:1
Completed:3
Trial Phases
2 Phases
Phase 1:2
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (66.7%)Phase 2
1 (33.3%)Safety Pilot Study of Farnesoid X Receptor (FXR) Agonist in Non-alcoholic Fatty Liver Disease (NAFLD) Patients
- First Posted Date
- 2013-12-03
- Last Posted Date
- 2016-09-29
- Lead Sponsor
- Phenex Pharmaceuticals AG
- Target Recruit Count
- 12
- Registration Number
- NCT01999101
- Locations
- 🇦🇹
Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Vienna, Austria
Multiple Ascending Oral Dose Phase I Study With Px-102
- First Posted Date
- 2013-12-02
- Last Posted Date
- 2014-11-04
- Lead Sponsor
- Phenex Pharmaceuticals AG
- Target Recruit Count
- 42
- Registration Number
- NCT01998672
- Locations
- 🇩🇪
FOCUS Clinical Drug Development GmbH, Neuss, Germany
Single Ascending Oral Dose Phase I Study With Px-102
- First Posted Date
- 2013-12-02
- Last Posted Date
- 2014-11-04
- Lead Sponsor
- Phenex Pharmaceuticals AG
- Target Recruit Count
- 54
- Registration Number
- NCT01998659
- Locations
- 🇩🇪
FOCUS Clinical Drug Development GmbH, Neuss, Germany
News
No news found